Muhammed Taha Esmeray

Muhammed Taha Esmeray

Auto-generated profile, based on publicly available information

Muhammed Taha Esmeray

Kemal Arıkan Psychiatry Clinic, Istanbul, Turkey

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 April 2024 in The World Journal of Biological Psychiatry
Verified
Journal Article
Closed access
MAMehmet Kemal Arikan
Mehmet Kemal Arikan
RIReyhan İlHan
Reyhan İlHan
ÖOÖzden Orhan
Özden Orhan
MEMuhammed Taha Esmeray
Muhammed Taha Esmeray
ŞTŞenol Turan
Şenol Turan
BMBarış Metin
Barış Metin
IntroductionMajor depression (MDD) is a mental health disorder characterized by persistent low mood or loss of interest lasting at least two weeks, with symptoms including lack of energy, sleep dis...

24 September 2021 in Psychiatry and Clinical Psychopharmacology
Verified
Journal Article
Open access
GGGuven Gunver
Guven Gunver
MSMustafa Senocak
Mustafa Senocak
RIReyhan Ilhan
Reyhan Ilhan
HAHazal Aktas
Hazal Aktas
SKSevgi Kilic
Sevgi Kilic
MAMehmet Kemal Arikan
Mehmet Kemal Arikan
Hamilton Depression Rating Scale,Hamilton Anxiety Rating Scale,sensitivity,specificity,receiver operating characteristic (ROC)

31 July 2023 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
MAMehmet Kemal Arikan
Mehmet Kemal Arikan
RIReyhan İlHan
Reyhan İlHan
MÖMahmut Taha Özulucan
Mahmut Taha Özulucan
MEMuhammed Taha Esmeray
Muhammed Taha Esmeray
GGGuven Gunver
Guven Gunver
Backgrounds: More than half of the patients with bipolar disorder (BD) had depressive episodes at the onset of BD. Despite some suggested clinical predictors, there are no certain criteria for predicting which unipolar depression patient switch to manic episodes during the treatment course. Electrophysiological markers can address this issue. Methods: Pretreatment quantitative electroencephalography (qEEG) records of patients diagnosed with major depressive disorder (MDD) or BD at the first visit were included in the study. Patients with MDD were also grouped with manic switch (MS) or MDD based on the diagnosis of later visits. The qEEG spectral power was analyzed across 3 groups, that is, MS, MDD, and BD. Results: Compared to patients whose diagnosis did not change, patients with MS had accelerated high-frequency activities predominantly in the left hemisphere (central-parietal-occipital regions). In contrast, they showed increased slow wave activity predominantly in the right hemisphere (parietal-occipital regions). Conclusion: It can be concluded that searching for electrophysiological markers, which have distinct advantages of repeatability, noninvasiveness, and cost-effectiveness, can facilitate the prediction of the MS.

20 November 2024 in Clinical Eeg and Neuroscience
Verified
Journal Article
Closed access
MAMurat Aşık
Murat Aşık
RIReyhan İlHan
Reyhan İlHan
MGMehmet Güven Günver
Mehmet Güven Günver
ÖOÖzden Orhan
Özden Orhan
MEMuhammed Taha Esmeray
Muhammed Taha Esmeray
MAMehmet Kemal Arikan
Mehmet Kemal Arikan
Backgrounds: Brain morphological biomarkers could contribute to understanding the treatment response in patients with obsessive-compulsive disorder (OCD). Multimodal neuroimaging addresses this issue by providing more comprehensive information regarding neural processes and structures. Objectives. The present study aims to investigate whether patients responsive to deep Transcranial Magnetic Stimulation (TMS) differ from non-responsive individuals in terms of electrophysiology and brain morphology. Secondly, to test whether multimodal neuroimaging is superior to unimodal neuroimaging in predicting response to deep TMS. Methods. Thirty-two OCD patients who underwent thirty sessions of deep TMS treatment were included in the study. Based on a minimum 50% reduction in Yale-Brown Obsessive Compulsive Scale (Y-BOCS) scores after treatment, patients were grouped as responders (n = 25) and non-responders (n = 7). The baseline resting state qEEG and magnetic resonance imaging (MRI) records of patients were recorded. Independent sample t-test is used to compare the groups. Then, three logistic regression model were calculated for only QEEG markers, only MRI markers, and both QEEG/MRI markers. The predictive values of the three models were compared. Results. OCD patients who responded to deep TMS treatment had increased Alpha-2 power in the left temporal area and increased volume in the left temporal pole, entorhinal area, and parahippocampal gyrus compared to non-responders. The logistic regression model showed better prediction performance when both QEEG and MRI markers were included. Conclusions. This study addresses the gap in the literature regarding new functional and structural neuroimaging markers and highlights the superiority of multimodal neuroimaging to unimodal neuroimaging techniques in predicting treatment response.